TSX: ACB
EDMONTON, Sept. 21, 2018 /CNW/ - Aurora Cannabis Inc.
("Aurora" or the "Company") (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM), today announced
that it has scheduled its conference call to discuss the results
for its fourth quarter ended June 30,
2018. The call will be hosted on Tuesday, September 25th, 2018 at
11:00 a.m. Eastern Time by
Terry Booth, Chief Executive
Officer, Glen Ibbott, Chief
Financial Officer, and Cam Battley,
Chief Corporate Officer followed by a question and answer
period.
CONFERENCE CALL
DETAILS
|
|
DATE:
|
Tuesday, September
25th, 2018
|
TIME:
|
11:00 a.m. Eastern
Time (9:00 a.m. Mountain Time)
|
WEBCAST:
|
https://bit.ly/2pnnKkA
|
DIAL IN
NUMBER:
|
(647) 427-7450 or
(888) 231-8191
|
REPLAY:
|
(416) 849-0833 or
(855) 859-2056
Available until 12:00 midnight Eastern Time Tuesday, October 2,
2018
|
REFERENCE
NUMBER:
|
2977713
|
About Aurora
Headquartered in Edmonton, Alberta,
Canada with funded capacity in excess of 500,000 kg per year
and sales and operations in 18 countries across five continents,
Aurora is one of the world's largest and leading cannabis
companies. Aurora is vertically integrated and horizontally
diversified across every key segment of the value chain, from
facility engineering and design to cannabis breeding and genetics
research, cannabis and hemp production, derivatives, high value-add
product development, home cultivation, wholesale and retail
distribution.
Highly differentiated from its peers, Aurora has established a
uniquely advanced, consistent and efficient production strategy,
based on purpose-built facilities that integrate leading-edge
technologies across all processes, defined by extensive automation
and customization, resulting in the massive scale production of
high quality product at ultra-low costs. Intended to be replicable
and scalable globally, these production facilities are designed to
produce cannabis of significant scale, with high quality,
industry-leading yields, and ultra-low per gram production costs.
Each of Aurora's facilities is built to meet European Union (EU)
GMP standards, and its first production facility, the recently
acquired MedReleaf Markham facility, and its wholly owned European
medical cannabis distributor Aurora Deutschland (formerly
Pedanios), have achieved this level of certification.
In addition to the Company's rapid organic growth and strong
execution on strategic M&A, which to date includes 15 companies
– MedReleaf, CanvasRX, Peloton Pharmaceutical, Aurora
Deutschland (formerly Pedanios), H2 Biopharma, Urban Cultivator, BC
Northern Lights, Larssen Greenhouses, CanniMed Therapeutics,
Anandia Labs, HotHouse Consulting, Agropro, Borela, and the pending
acquisition of ICC Labs – Aurora is distinguished by its reputation
as a partner of choice and employer of choice in the global
cannabis sector, having invested in and established strategic
partnerships with a range of leading innovators, including: The
Green Organic Dutchman Holdings Ltd. (TSX: TGOD), Radient
Technologies Inc. (TSXV: RTI), Hempco Food and Fiber Inc. (TSXV:
HEMP), Cann Group Ltd. (ASX: CAN), Micron Waste Technologies Inc.
(CSE: MWM), Choom Holdings Inc. (CSE: CHOO), Namaste Technologies
Inc. (TSXV: N), Evio Beauty Group (private), Wagner Dimas
(private), CTT Pharmaceuticals (OTCC: CTTH), and Alcanna Inc. (TSX:
CLIQ).
Aurora's Common Shares trade on the TSX under the symbol "ACB",
and are a constituent of the S&P/TSX Composite Index.
For more information about Aurora, please visit our investor
website, investor.auroramj.com, Twitter, Facebook or Instagram
Terry Booth, CEO
Aurora Cannabis Inc.
Forward looking statements
This news release includes statements containing certain
"forward-looking information" within the meaning of applicable
securities law ("forward-looking statements"). Forward-looking
statements are frequently characterized by words such as "plan",
"continue", "expect", "project", "intend", "believe", "anticipate",
"estimate", "may", "will", "potential", "proposed" and other
similar words, or statements that certain events or conditions
"may" or "will" occur. These statements are only predictions.
Various assumptions were used in drawing the conclusions or making
the projections contained in the forward-looking statements
throughout this news release. Forward-looking statements are based
on the opinions and estimates of management at the date the
statements are made, and are subject to a variety of risks and
uncertainties and other factors that could cause actual events or
results to differ materially from those projected in the
forward-looking statements. The Company is under no obligation, and
expressly disclaims any intention or obligation, to update or
revise any forward-looking statements, whether as a result of new
information, future events or otherwise, except as expressly
required by applicable law.
Neither TSX nor its Regulation Services Provider (as that term
is defined in the policies of Toronto Stock Exchange) accepts
responsibility for the adequacy or accuracy of this release.
SOURCE Aurora Cannabis Inc.